Sign in to follow
Search Results

0 results for 'Gilead Sciences'

You can use to get even better search results
March 22, 2024 | Corporate Counsel

Kirkland & Ellis to Represent Apple in Landmark Antitrust Lawsuit

The Kirkland team includes star litigators as well as a partner who spent 13 years at the Federal Trade Commission.
3 minute read
March 20, 2024 | Delaware Business Court Insider

Superior Court: More Overlap in Case Facts Needed for Insurer to Deny D&O Coverage

Delaware Superior Court Judge Paul R. Wallace granted a California-based biotech company's motion for partial summary judgment.
3 minute read
March 19, 2024 | National Law Journal

Wilmer's Revenue and Profits Soar Amid Boom in Countercyclical Practices

While the firm landed in the spotlight for its clients' congressional testimony, Wilmer's revenue and profit grew 10% or more in 2023, amid gains in litigation and investigations practices.
4 minute read
March 18, 2024 | The American Lawyer

Kirkland Crosses $7B Mark, With Steady And Countercyclical Business Drivers

The firm continued to improve its profit margin, as average PEP rose nearly 6% to $7.955 million, according to American Lawyer reporting.
5 minute read
March 13, 2024 | Corporate Counsel

After Honing Skills at Pharma Heavyweight, Attorney Takes First GC Post

"I love the fast pace and urgency," said Andy Rittenberg, the newly appointed general counsel of Coherus BioSciences. "We have a lot on our plates and accomplish a lot with a small team."
2 minute read
Law Journal Press | Digital Book State Antitrust Law Authors: William T. Lifland View this Book

View more book results for the query "Gilead Sciences"

March 06, 2024 | The American Lawyer

Proskauer Sees Slight Revenue Drop, Showing 'Great Strength' With Headwinds

After client activity slowed down in 2023, chair-elect Timothy Mungovan said Proskauer is very bullish on 2024.
6 minute read
March 04, 2024 | The Recorder

How a Recent California Appellate Court Decision Will Chill Drug Development, Raise Pharmaceutical Costs

"In allowing this case to proceed, California outdid itself by threatening the core of pharmaceutical innovation in this country," according to Jeremy Kidd, law professor at Drake University Law School.
4 minute read
February 12, 2024 | The American Lawyer

Deal Watch: Wachtell, Paul Weiss and V&E Lead $26B Oil Merger as Deal Activity Soars

Energy and life sciences continue to lead the way in deal activity, but tech and other recently nascent sectors are showing signs of life.
12 minute read
Gilead Tenofovir Cases
Publication Date: 2024-01-16
Practice Area: Business Torts
Industry: Pharmaceuticals
Court: Court of Appeal, 1st District
Judge: Justice Goldman
Attorneys:
For plaintiff:
For defendant:
Case number: A165558

Negligence claim against drug manufacturer may be based on factors other than design defect

TRENDING STORIES

    More from ALM

    More from ALM

    Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

    Resources

    • Revenue, Profit, Cash: Managing Law Firms for Success

      Brought to you by Juris Ledger

      Download Now

    • Law Firm Operational Considerations for the Corporate Transparency Act

      Brought to you by Wolters Kluwer

      Download Now

    • The Ultimate Guide to Remote Legal Work

      Brought to you by Filevine

      Download Now

    • Practical Guidance Journal: Protecting Work Product in a Generative AI World

      Brought to you by LexisNexis®

      Download Now